03/29/2024
1:41 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:15 AM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
3:31 PM | Avenue Therapeutics (Filer)
| Form PRE 14C | |
02/23/2024
3:17 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
01/29/2024
7:00 AM | Avenue Therapeutics (Filer)
| Form DEF 14C | |
01/17/2024
4:05 PM | Avenue Therapeutics (Filer)
| Form PRE 14C | |
|
01/12/2024
5:01 AM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
4:28 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
2:45 PM | Avenue Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/28/2023
3:01 PM | Avenue Therapeutics (Issuer)
Davidow Robert L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/24/2023
12:19 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:10 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
8:00 AM | Avenue Therapeutics (Filer)
| Form 424B4 | |
10/31/2023
11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
10/23/2023
7:50 PM | Avenue Therapeutics (Filer)
| Form S-1/A | |
10/05/2023
4:05 PM | Avenue Therapeutics (Subject)
| Form FWP | |
09/29/2023
4:23 PM | Avenue Therapeutics (Filer)
| Form S-1/A | |
09/28/2023
3:25 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
4:08 PM | Avenue Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
09/18/2023
4:18 PM | Avenue Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/12/2023
8:02 AM | Avenue Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
8:03 AM | Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:37 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
12:05 PM | Avenue Therapeutics (Issuer)
MacLean Alexandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
06/26/2023
3:15 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:31 PM | Avenue Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/12/2023
3:15 PM | Avenue Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2023
7:35 AM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
3:30 PM | Avenue Therapeutics (Filer)
| Form 424B3 | |
05/03/2023
11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
